Bank of New York Mellon
RXST icon

Bank of New York Mellon’s RxSight RXST Stock Holding History

Bank of New York Mellon’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Buy
120,094
+19,788
+20% +$119K ﹤0.01% 3676
2026
Q1 		$618K Buy
100,306
+5,978
+6% +$49.6K ﹤0.01% 3497
2025
Q4 		$983K Sell
94,328
-12,070
-11% -$121K ﹤0.01% 3249
2025
Q3 		$957K Sell
106,398
-165
-0.2% -$1.45K ﹤0.01% 3236
2025
Q2 		$1.39M Buy
106,563
+2,904
+3% +$43.7K ﹤0.01% 2935
2025
Q1 		$2.62M Buy
103,659
+777
+0.8% +$23.1K ﹤0.01% 2561
2024
Q4 		$3.54M Buy
102,882
+9,385
+10% +$423K ﹤0.01% 2479
2024
Q3 		$4.62M Sell
93,497
-25,996
-22% -$1.33M ﹤0.01% 2328
2024
Q2 		$7.19M Buy
119,493
+17,368
+17% +$993K ﹤0.01% 2141
2024
Q1 		$5.27M Sell
102,125
-10,535
-9% -$517K ﹤0.01% 2301
2023
Q4 		$4.54M Buy
112,660
+6,457
+6% +$189K ﹤0.01% 2417
2023
Q3 		$2.96M Buy
106,203
+3,132
+3% +$93.4K ﹤0.01% 2585
2023
Q2 		$2.97M Buy
103,071
+37,413
+57% +$832K ﹤0.01% 2612
2023
Q1 		$1.1M Buy
65,658
+8,906
+16% +$126K ﹤0.01% 3098
2022
Q4 		$719K Sell
56,752
-136
-0.2% -$1.65K ﹤0.01% 3354
2022
Q3 		$683K Buy
56,888
+5,614
+11% +$77.1K ﹤0.01% 3393
2022
Q2 		$722K Buy
51,274
+12,611
+33% +$166K ﹤0.01% 3364
2022
Q1 		$479K Buy
38,663
+21,385
+124% +$257K ﹤0.01% 3733
2021
Q4 		$195K Buy
17,278
+2,065
+14% +$24.8K ﹤0.01% 4280
2021
Q3 		$193K Buy
+15,213
New +$209K ﹤0.01% 4225

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CLA
Carnegie Lake Advisors Princeton, New Jersey $268M AUM 22.32% 1-Year Est. Return

Bank of New York Mellon's RXST Position: Q2 2026 in Review

Bank of New York Mellon increased its RxSight (RXST) stake by 20% in Q2 2026, buying an estimated $119K and bringing the position to 120,094 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #3676.

Bank of New York Mellon first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.19M in Q2 2024. 53 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Bank of New York Mellon held 120,094 shares of RxSight worth $579K as of Q2 2026.
  • Bank of New York Mellon bought 19,788 RxSight shares in Q2 2026, an estimated $119K.
  • RxSight made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3676 holding.
  • Bank of New York Mellon first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Bank of New York Mellon's RxSight position peaked at $7.19M in Q2 2024.
  • 53 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.